Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANI Pharmaceuticals

62.56
+0.44000.71%
Post-market: 62.560.00000.00%16:04 EDT
Volume:150.69K
Turnover:9.37M
Market Cap:1.36B
PE:-59.99
High:62.58
Open:61.37
Low:61.18
Close:62.12
Loading ...

ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Raised

MT Newswires Live
·
09 May

ANI Pharmaceuticals Shares up 3.5% Premarket After Co Lifts 2025 Profit Forecast

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Q1 2025 Adj. EPS $1.70 Beats $1.38 Estimate, Sales $197.12M Beat $180.68M Estimate

Benzinga
·
09 May

BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 1.7 Vs. IBES Estimate USD 1.38

Reuters
·
09 May

ANI Pharmaceuticals Outlook FY Adjusted EPS USD 6.27-6.62

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Inc - 2025 Guidance Raised, Expected Net Revenues $768-$793 Million

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Q1 Revenue USD 68.959 Million VS. Ibes Estimate USD 180.7 Million

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

Zacks
·
06 May

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

GlobeNewswire
·
05 May

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks
·
02 May

3 Reasons Growth Investors Will Love ANI (ANIP)

Zacks
·
26 Apr

5 Stocks With Recent Price Strength Amid Tariff-Led Volatility

Zacks
·
23 Apr

4 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks
·
22 Apr

ANI Pharmaceuticals Is Maintained at Hold by Truist Securities

Dow Jones
·
22 Apr

ANI Pharmaceuticals Inc : Truist Securities Raises Target Price to $65 From $62

THOMSON REUTERS
·
21 Apr

Truist Lifts Price Target on ANI Pharmaceuticals to $65 From $62, Keeps Hold Rating

MT Newswires Live
·
21 Apr

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?

Zacks
·
17 Apr

SRPT Provides Pipeline Updates on Rare Muscular Disorder Therapies

Zacks
·
16 Apr

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

StockStory
·
15 Apr